Pharma · Semiconductors · Rare Earths · PPE · Power Grid · Shipping · Drones · Any Critical Supply Chain
The United States has built a $27 trillion economy on a global supply chain optimized for cost — not security. That supply chain runs through adversaries, through geopolitically unstable regions, and through layers of intermediaries specifically designed to obscure origin.
Essential drugs are mainly manufactured in China and India. Personal protective equipment had been almost entirely offshored to Chinese factories. Asian dependencies on semiconductors has impacted American automobile production, grounded defense procurement timelines, and reminded Washington that the microchips inside every weapons system, every power grid controller, and every communications network were being fabricated in Taiwan and South Korea — within Chinese missile range.
Rare earth elements critical to electric vehicles, guided munitions, and satellite systems are processed almost exclusively in China. The shipping container infrastructure that moves 90% of global trade runs through Chinese-owned terminals on every major ocean. The commercial drones flying over American infrastructure are manufactured overwhelmingly by DJI, a company with documented ties to the People’s Liberation Army.
It is time for a real time surveillance solution. AI driven, equipped to handle the complex, constantly changing global supply chain that provides the products the American economy runs on. TheTradeSpy.ai is the genesis of that solution.
TheTradeSpy.ai is an AI-powered Supply Chain Intelligence Platform built to answer the question that underlies every critical purchasing decision: where does this actually come from — and who controls it?
The platform deploys autonomous AI agent swarms against federal regulatory records, corporate filings, trade statistics, geopolitical databases, sanctions lists, ownership registries, and political disclosure data to produce a verified, auditable intelligence profile for any product in the U.S. market.
"The platform’s architecture is sector-agnostic. The same field agents, analyst agents, and evidence framework that maps pharmaceutical supply chains can map semiconductors, rare earths, power grid components, PPE, shipping infrastructure, and drone supply chains with equal precision."
The CCP hard floor is enforced in code — not in an AI prompt. No quality certification, no domestic manufacturing bonus, no human override can pull a flagged product below HIGH risk. That is not policy. That is architecture.
This is a production intelligence platform built by operators who lived the supply chain crisis firsthand. What follows is the case file.
FDA labeler records identify the U.S. marketing entity that filed the application — not the facility where the drug was manufactured.
"Manufactured For" shell arrangements, U.S. HQ conflation, and CMO cascading have made it structurally impossible to trace origin from label alone.
Over 80% of U.S. drug APIs are sourced overseas. The FDA inspected 28% of Chinese pharmaceutical facilities in FY2024. For the remaining 72%, procurement officers are buying from facilities they cannot identify — because the label points to a U.S. subsidiary, not the factory.
TheTradeSpy.ai closes that gap. Every determination. Every NDC. Full evidence trail.
// SECTOR-AGNOSTIC: pharma · semiconductors · rare earths · PPE · power grid · shipping · drones
The Label Lies.
TheTradeSpy.ai Doesn't.
A product labeled Made in France may carry 33% China API dependency. A product with a New York headquarters may have its active pharmaceutical ingredient manufactured in Wuhan. Neither fact appears on the label.
TheTradeSpy.ai reveals upstream ingredient exposure using real, verifiable import / export global trade data — not inference, not sampling, not self-reported attestation. Actual trade flows. Actual countries. Actual percentages.
Every determination carries its evidence: the source, the timestamp, the confidence tier, and the specific factor that drove the conclusion. The audit trail is the product.
Code.
Not Policy.
Not Advisory.
Competitor platforms flag CCP risk as advisory — a warning that can be overridden by a quality certification, a domestic manufacturing bonus, or a human reviewer. In TheTradeSpy.ai, that is not how it works.
The CCP hard floor is enforced deterministically in Python. It screens every Chinese-nexus manufacturer across 13 sources: OFAC · Entity Lists · SOE Registries · PLA Affiliation · Political Membership. If a manufacturer is flagged, the product scores HIGH.
No AI prompt. No certification. No override. No exception. That is an architectural commitment to procurement integrity.
Built by the
Operators Who
Lived It.
TheTradeSpy.ai is built on 18 years of operations inside the supply chain it maps. The founding team has imported over one billion medical devices, supplies and drugs for the DoD, other government agencies, and commercial hospitals and healthcare providers.
The data gaps TheTradeSpy.ai closes were not discovered through academic analysis. They were discovered by executing real transactions in a broken system, testifying before the U.S. Senate, and briefing the White House on foreign API dependency.
The platform is the product of that experience. That is why nothing else compares.
Three Intelligence
Layers
30+ Agents.
Zero Manual Updates.
Continuous Operation.
30+ autonomous AI agents run around the clock — 25+ field agents collecting evidence from federal and commercial databases, 6+ analyst agents applying the 44-factor model, an independent Reconciler validating every conclusion, and a Data Inspector flagging discrepancies, stale data, and scoring improvements.
Every competitor relies on periodic manual data refreshes. TheTradeSpy.ai's agents continuously collect, score, and reconcile — with news risk signals updating every 4 hours. The system gets more accurate over time.
30 agents vs. quarterly updates. Continuous vs. periodic. Evidence-backed vs. self-reported. CCP floor in code vs. advisory flag. Political exposure visible vs. invisible. Natural language vs. SQL.
Ask it anything — "List all products from CCP-flagged manufacturers in the cardiovascular formulary" — and get an intelligence briefing in seconds.
US 11,860,967 · Descriptor Normalization
US 12,332,966 · Supply-Chain Task Automation
US 12,468,774 · Data Reacquisition
US 11,640,440 · Website Data Modeling
US 11,416,575 · Multi-Platform Task Execution
US 11,568,019 · Function Description Modeling
US 11,580,190 · Substitute Task Handling
US 12,259,940 · ML-Based Data Modeling
US 12,326,913 · Complex Task Fault Recovery
VA, DoD, and Federal Contracting Officers
Instant BAA/TAA eligibility determination for every product. COO evidence audit trail. Domestic alternatives with side-by-side MIA score comparison. Executive briefings formatted for Congressional staff and C-suite. Natural language queries that return intelligence briefings in seconds.
The SRI Risk Index provides a composite national risk score — a single number for portfolio-level procurement decisions.
NAICS: 541519 · 541690 · 611430
Small Business · For-Profit Corporation
HQ: Stuart, Florida
Formulary Managers and Supply Chain Teams
Upload your formulary. Receive a portfolio risk report — aggregate risk score, country concentration, China dependency by therapeutic class, shortage early warning on every product, and domestic alternative recommendations with side-by-side pricing.
The 30/60/90-day shortage radar provides the lead time to act before a disruption becomes a crisis. Therapeutic alternative mapping delivers a specific domestic substitute.
Companies That Make Drugs in America
If your drugs are manufactured in the United States, TheTradeSpy.ai gives you a direct path to prove it — with verified claims reflected across every government and hospital procurement workflow using the platform.
The Self-Attestation System allows manufacturers to submit documented domestic manufacturing claims. Email domain verification, admin review, full audit trail. Approved attestations set COO confidence to 100% Made-in-America and propagate immediately.